RLFTY — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
$0.42
Market Cap
$66.59M
52W High
$2.40
52W Low
$0.27
ADV30
233
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$642,000
EBITDA
$-9,143,000
Free Cash Flow
—
Enterprise Value
—
Total Cash
—
Total Debt
—
Shares Out
157,602,044
Trailing EPS
$-0.59
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 642,000 | -10,515,000 | -9,906,000 | 51,530,000 | 13,189,000 | — | -7,208,000 |
| Dec 2024 | 0 | -2,000 | -1,000 | 93,000 | 7,000 | — | -3,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HYFT | MindWalk Holdings Corp. | $66.80M | $1.43 | — |
| CING | Cingulate Inc. | $66.13M | $4.91 | — |
| PMVP | PMV Pharmaceuticals, Inc. | $66.13M | $1.24 | — |
| EDSA | Edesa Biotech, Inc. | $67.53M | $7.01 | — |
| MNOV | MEDICINOVA INC | $68.42M | $1.39 | — |
News headlines (Yahoo Finance, 1h cache)
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
2026-07-09 05:35 · Yahoo
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
2026-07-01 05:22 · Yahoo
MindMaze Therapeutics Announces Results of Annual General Meeting
2026-06-25 20:32 · Yahoo
MindMaze Therapeutics Publishes Invitation to the 2026 Annual General Meeting
2026-06-03 05:00 · Yahoo
MindMaze Therapeutics Announces Non-Core Asset Sale and Organizational Simplification
2026-06-02 05:05 · Yahoo
MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 06:30 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.